1. Home
  2. CSBR vs HNNA Comparison

CSBR vs HNNA Comparison

Compare CSBR & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$6.25

Market Cap

83.5M

Sector

Health Care

ML Signal

N/A

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

N/A

Current Price

$9.95

Market Cap

81.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CSBR
HNNA
Founded
1985
1989
Country
United States
United States
Employees
N/A
18
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
81.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CSBR
HNNA
Price
$6.25
$9.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7K
4.6K
Earning Date
03-12-2026
05-11-2026
Dividend Yield
N/A
5.57%
EPS Growth
161.11
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
$8.77
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$8.90
52 Week High
$9.63
$13.19

Technical Indicators

Market Signals
Indicator
CSBR
HNNA
Relative Strength Index (RSI) 57.68 50.11
Support Level $6.14 $9.71
Resistance Level $6.29 $10.00
Average True Range (ATR) 0.25 0.16
MACD 0.03 -0.01
Stochastic Oscillator 79.71 44.44

Price Performance

Historical Comparison
CSBR
HNNA

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

Share on Social Networks: